v3.25.1

Intangible assets other than goodwill | 12 Months Ended
--- | ---
Dec. 31, 2024
Intangible assets other than goodwill. |
Intangible assets other than goodwill | 14. Intangible assets other than goodwill ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Software & databases |  | Licenses, technology and in-process R&D |  | ​ | Exclusive rights |  | Contract costs |  | Total
​ | ​ | (Euro, in thousands)
Acquisition value | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
On January 1, 2023 | ​ | € | 27,377 | ​ | € | 44,258 | ​ | € | 89,720 | ​ | € | 15,384 | ​ | € | 176,740
Additions | ​ | ​ | 567 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 567
Sales and disposals | ​ | ​ | (930) | ​ | ​ | (948) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (1,878)
Translation differences | ​ | ​ | ​ | ​ | ​ | (139) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (139)
On December 31, 2023 | ​ | € | 27,014 | ​ | € | 43,171 | ​ | € | 89,720 | ​ | € | 15,384 | ​ | € | 175,290
Additions | ​ | ​ | 666 | ​ | ​ | ​ | ​ | ​ | 64,725 | ​ | ​ | ​ | ​ | ​ | 65,391
Sales and disposals | ​ | ​ | (1,863) | ​ | ​ | (3,613) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (5,476)
Reclassifications | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | —
Translation differences | ​ | ​ | ​ | ​ | ​ | 246 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 246
On December 31, 2024 | ​ | € | 25,817 | ​ | € | 39,804 | ​ | € | 154,445 | ​ | € | 15,384 | ​ | € | 235,451
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amortization and impairment | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
On January 1, 2023 | ​ | € | 15,210 | ​ | € | 3,896 | ​ | € | 6,154 | ​ | € | 5,126 | ​ | € | 30,387
Amortization | ​ | ​ | 4,291 | ​ | ​ | 1,426 | ​ | ​ | 11,637 | ​ | ​ | 1,538 | ​ | ​ | 18,892
Sales and disposals | ​ | ​ | (927) | ​ | ​ | (948) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (1,875)
Translation differences | ​ | ​ | ​ | ​ | ​ | (20) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (20)
On December 31, 2023 | ​ | € | 18,574 | ​ | € | 4,354 | ​ | € | 17,791 | ​ | € | 6,664 | ​ | € | 47,384
Amortization | ​ | ​ | 4,384 | ​ | ​ | 493 | ​ | ​ | 22,198 | ​ | ​ | 1,538 | ​ | ​ | 28,613
Impairment | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | —
Sales and disposals | ​ | ​ | (1,863) | ​ | ​ | (3,613) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | (5,476)
Translation differences | ​ | ​ | ​ | ​ | ​ | 68 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 68
On December 31, 2024 | ​ | € | 21,095 | ​ | € | 1,302 | ​ | € | 39,989 | ​ | € | 8,202 | ​ | € | 70,589
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Carrying amount | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
On December 31, 2023 | ​ | € | 8,440 | ​ | € | 38,817 | ​ | € | 71,929 | ​ | € | 8,720 | ​ | € | 127,906
On December 31, 2024 | ​ | € | 4,722 | ​ | € | 38,502 | ​ | € | 114,456 | ​ | € | 7,182 | ​ | € | 164,862
​ ​ Through the acquisition of CellPoint and AboundBio in June 2022, we acquired in-process research and development related to two CAR-T product candidates (€28.2 million on December 31, 2024, and on December 31, 2023), exclusive rights and technology, being a fully human therapeutics platform. These exclusive rights refer to our exclusivity contract with Lonza (€60.3 million on December 31, 2024, €71.9 million on December 31, 2023) and are depreciated until the beginning of March 2030, in accordance with the contract. The addition in exclusive rights in 2024 refers to the upfront exclusivity consideration paid to Adaptimmune of $70.0 million, which is amortized over the expected exclusivity period until the end of 2027. On December 31, 2024, our statement of financial position did not hold any internally generated assets capitalized as intangible asset.

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfIntangibleAssetsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 38 -IssueDate 2024-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfIntangibleAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration